Rasagiline (Azilect)

Primer

Rasagiline is a monoamine oxidase inhibitor (MAOI). It is used in the treatment of Parkinson's disease.

Mechanism of Action

  • Rasagiline is a centrally acting monoamine oxidase type B (MAO-B) inhibitor.
    • It increases dopamine levels by these drugs reducing the breakdown of dopamine generated from levodopa in the central nervous system.